A comparison between edaravone (RadicavaTM )and riluzole regarding indication and efficacy in ALS patients

Bibliographic Details
Main Author:	Rantapää, Johanna Linna
Format:	Others
Language:	English
Published:	Umeå universitet, Farmakologi 2018
Subjects:	Other Medical Sciences Annan medicin och hälsovetenskap
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-148501

id	ndltd-UPSALLA1-oai-DiVA.org-umu-148501
record_format	oai_dc
spelling	ndltd-UPSALLA1-oai-DiVA.org-umu-1485012018-06-07T05:23:46ZA comparison between edaravone (RadicavaTM )and riluzole regarding indication and efficacy in ALS patientsengRantapää, Johanna LinnaUmeå universitet, Farmakologi2018Other Medical SciencesAnnan medicin och hälsovetenskapStudent thesisinfo:eu-repo/semantics/bachelorThesistexthttp://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-148501application/pdfinfo:eu-repo/semantics/openAccess
collection	NDLTD
language	English
format	Others
sources	NDLTD
topic	Other Medical Sciences Annan medicin och hälsovetenskap
spellingShingle	Other Medical Sciences Annan medicin och hälsovetenskap Rantapää, Johanna Linna A comparison between edaravone (RadicavaTM )and riluzole regarding indication and efficacy in ALS patients
author	Rantapää, Johanna Linna
author_facet	Rantapää, Johanna Linna
author_sort	Rantapää, Johanna Linna
title	A comparison between edaravone (RadicavaTM )and riluzole regarding indication and efficacy in ALS patients
title_short	A comparison between edaravone (RadicavaTM )and riluzole regarding indication and efficacy in ALS patients
title_full	A comparison between edaravone (RadicavaTM )and riluzole regarding indication and efficacy in ALS patients
title_fullStr	A comparison between edaravone (RadicavaTM )and riluzole regarding indication and efficacy in ALS patients
title_full_unstemmed	A comparison between edaravone (RadicavaTM )and riluzole regarding indication and efficacy in ALS patients
title_sort	comparison between edaravone (radicavatm )and riluzole regarding indication and efficacy in als patients
publisher	Umeå universitet, Farmakologi
publishDate	2018
url	http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-148501
work_keys_str_mv	AT rantapaajohannalinna acomparisonbetweenedaravoneradicavatmandriluzoleregardingindicationandefficacyinalspatients AT rantapaajohannalinna comparisonbetweenedaravoneradicavatmandriluzoleregardingindicationandefficacyinalspatients
_version_	1718692941662257152

A comparison between edaravone (RadicavaTM )and riluzole regarding indication and efficacy in ALS patients

Similar Items